JVM-3人前B淋巴細(xì)胞白血病
具體成交價以合同協(xié)議為準(zhǔn)
- 公司名稱 上海富雨生物科技有限公司
- 品牌
- 型號
- 產(chǎn)地
- 廠商性質(zhì) 生產(chǎn)廠家
- 更新時間 2025/4/24 14:51:15
- 訪問次數(shù) 76
聯(lián)系方式：陳壽彬18956075901 查看聯(lián)系方式
聯(lián)系我們時請說明是化工儀器網(wǎng)上看到的信息，謝謝!
JVM-3 人慢性髓白血病細(xì)胞
Catalogue No.: C1308
Product Format: a 15 ml centrifuge tube
Culture Properties：懸浮
Complete Growth Medium: 89%IMDM+10%FBS+1%雙抗
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Application: Cells and cancer research
NOTE: FOR RESEARCH USE ONLY.
Components
（同微信）
(21). In this cohort, bone metastases were present in 31.4% (16/51) of T- NEN patients, which is consistent with the incidence of 33% reported in the literature (22). Currently, there is no reliable biomarker that can predict bone metastasis in T-NEN, and no underlying mechanisms have been uncovered to address the issue. In our series, a signi?cant correlation between bone metastasis and the level of CD8+ TILs was reported for
Catalogue No.: C1308
Product Format: a 15 ml centrifuge tube
Culture Properties：懸浮
Complete Growth Medium: 89%IMDM+10%FBS+1%雙抗
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Application: Cells and cancer research
NOTE: FOR RESEARCH USE ONLY.
Components
| Item | Specifications |
| a 15 ml centrifuge tube | 2X106 |
| Manual | 1 copy |
（同微信）
(21). In this cohort, bone metastases were present in 31.4% (16/51) of T- NEN patients, which is consistent with the incidence of 33% reported in the literature (22). Currently, there is no reliable biomarker that can predict bone metastasis in T-NEN, and no underlying mechanisms have been uncovered to address the issue. In our series, a signi?cant correlation between bone metastasis and the level of CD8+ TILs was reported for
采購中心
化工儀器網(wǎng)